focus -WSS

focus

author：explore 2025-10-01 23:38:53 - browse：16

When is a failure not a failure? Does the FDA have special rules for Sarepta Therapeutics? And how do you say “brash” in French?

We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. Biotech consultant Frank David joins us to explain the wild world of subgroup analyses and how to discern science from spin. We also discuss the latest news in the life sciences, including the future of Sarepta and the retirement of a biotech stalwart.

For more on what we cover, here’s where you can read Frank’s work; here’s more on Sarepta; here’s where you can find episodes of Color Code; here’s where you can subscribe to the First Opinion Podcast; and here’s where you can subscribe to our biotech newsletter, The Readout.

Be sure to sign up on Apple Podcasts, Spotify, Stitcher, TuneIn, or wherever you get your podcasts.

And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].

Previous article： Alkermes shareholders re
Next article： Diagnostic tests are hitting their mathematical limits

hotspot

WSS

Despite FDA concern, risk that CAR

U.K. Biobank has 500,000 peoples' genome sequences available

Medicare explains how it will choose drugs for negotiation

How a symptom of dementia informs our understanding of creativity

UnitedHealth has 90,000 doctors — 10% of all physicians in U.S.

BIO selects John Crowley as new CEO

explore

focus

leisure time

Moonlake's readout produced a cash windfall. Risks remain

Study finds new variant for Parkinson’s in African populations

Moonlake's readout produced a cash windfall. Risks remain

FDA panel gives mixed vote on blood pressure devices

After affirmative action ruling, medical educators look to 'holistic review'

How to pay for weight loss drugs and save Medicare

What does generative AI mean for health care? We asked experts

CDC advisory panel says seniors 'may' get RSV vaccine

Affirmative action in medical school literally saved lives

As biotech industry slumps, bioscience job market is upside down

hotspot

FDA investigates CAR

What don’t we know about an Alzheimer’s drug side effect?

As pharma fights Medicare drug negotiation, hospitals, docs silent

AstraZeneca challenges Medicare drug negotiation program

What AAP's gender

Unicorn down: Following layoffs, Biofourmis CEO quietly departs

focus

focus

hotspot

explore